 MED. (J7 Clin Pathol 1995;48:768-770) 
Monocyte esterase is an enzyme unique to cells of monocytic lineage.' It is characterised in vitro by a positive reaction to the non-specific esterase cytochemical stain2 based on its ability to de-acylate napthyl acetate or butyrate and also identified by its specific isoelectric focus on polyacrylamide gels.3 Using an automated cytochemistry analyser, it has been previously demonstrated that monocyte esterase deficiency (MED; defined as the consistent presence of >85% esterase negative monocytes in a subject's peripheral blood) occurs in 0-8% of blood donors (four of 474) and significantly more frequently in patients with immunoproliferative (7A4%; 18 Paraoxonase activity with 1 M NaCl Arylesterase activity
The A phenotype was taken as a P:A ratio of <2x5 x 103, the AB phenotype as a ratio of >2-5 and <5-0 x 103 and the B phenotype as
Red cell cholinesterase (acetylcholinesterase) Red cell cholinesterase was measured using a method based on that of Ellman et al'6 and adapted for use on the COBAS FARA (Roche Products Ltd, Welwyn Garden City, UK). The washed packed cells were lysed with saponin (50 gl cells in 1 ml saponin (100 mg/dl)).
Acetyl(-methyl)thiocholineiodide (7 mM/l) in a 0-1 M phosphate buffer (pH 7 2) was used as substrate2' and the thiocholine produced reacted with dithionitrobenzoate to give a yellow colour which was monitored at 412 nm. The reaction was carried out at 37°C. Ninety EDTA blood samples collected from a hospital and general practice population gave a range of 54-11 9 KU/I (median 8 1 KU/1, quartiles 7*5 KU/i and 8 8 KU/1).
STATISTICS
The We found more of the non-A phenotypes in both groups than has been previously reported,23 24 but the number of subjects included in the study is small; the discrepancy in the number of A phenotypes shown in the control group by the two methods was probably be- in my view, the just as extreme idea that they should do nothing apart from reporting negative cervical smears and possibly loading endoscopic biopsy specimens into cassettes, is proposed by the College and policed by the CPA, there is silence. As a grass roots pathologist who (to comply with accreditation requirements) has just waded through a lake of negative urine cytology and sputa without a hint of a malignant cell I feel this silence should be broken.
A competent MLSO should be able to report a negative urine or sputum and pass on a doubtful case to a pathologist; this is surely easier than the screening of cervical smears. The overall responsibility is still the pathologist's for ensuring that this is done safely but in a service which is consultant based in most non-teaching hospitals it is a waste of consultant time to report this kind of material. I wrote to the CPA recently to confirm their position on this. My heart sank to learn, I quote, that these are "mainly diagnostic specimens" and that the "responsibility for reporting them lies with the pathologist". This was based on the Authoritative Guidelines for Histopathology Laboratories published by The Royal College of Pathologists in 1989! Are they really mainly diagnostic specimens or are they much more the equivalent of a full blood count carried out when a patient has a particular symptom complex? I think the latter. I know that quite a few of my colleagues at other hospitals are paying lip service to this accreditation requirement. This is dangerous medicolegally; if I put my name to a report it implies that I have looked at the slides carefully.
A lot has changed since 1989. The present policy is bizarre and should be reviewed urgently. Is it right that at a time when in other branches of medicine there is ever increasing delegation of responsibility, even the possibility that nurses will one day carry out endoscopies, we are heading in the opposite direction. I am very worried that pathology in its terror of occasional mistakes being made, which are after all inevitable even if all urines and sputa were reported by professors of pathology, is losing its way and is increasingly out of step with the rest of medicine. A profession afraid to delegate sensibly will eventually be forced to do so by others. 
